ERBB2 and meningioma: Loussouarn et al. (7) examined 35 meningiomas (17 grade I and 18 grades II and III) and identified ERBB2 expression in 28.5% of cases, with 29.4% of grade I and 26.6% of grades II and III lesions positive.